夏云松,付建宇,刘旭,毕红英,陈林林,董奇,唐艳,王迪芬
XIA Yunsong,FU Jianyu,LIU Xu,BI Hongyin,CHEN Linlin,DONG Qi,TANG Yan,WANG Difen

• 1:贵州医科大学附属医院重症医学科

摘要(Abstract)：

目的:探讨BS330与AR350两种吸附柱对高胆红素血症重症患者的治疗效果。方法:收集同期收治的使用吸附柱治疗的高胆红素血症患者44例,根据患者使用吸附柱情况分为BS330组及AR350组,收集2组患者年龄、性别、APACHE Ⅱ评分、住ICU时间及预后资料;于治疗前及吸附治疗后30 min采集患者全血,检测总胆红素(TBL)、直接胆红素(DBL)、间接胆红素(IDBL)、谷丙转氨酶(AST)、谷草转氨酶(ALT)、胆汁酸(TBA)及血小板(PLT),比较上述各项指标的下降率。结果:2组患者男女构成比、年龄、APACHE Ⅱ评分、住ICU时间及预后比较,差异无统计学意义(P> 0.05);治疗前,2组患者TBL、DBL、IDBL、AST、ALT、TBA及PLT比较,差异无统计学意义(P> 0.05);治疗后,除AR350组IDBL较治疗前明显降低(P <0.05),其余指标比较差异无统计学意义(P> 0.05); 2组患者治疗后TBL、DBL、IDBL、ALT、AST及PLT下降率比较,差异无统计学意义(P> 0.05),BS330组患者TBA下降率明显高于AR350组,差异有统计学意义(P <0.05)。结论:BS330与AR350对高胆红素血症重症患者治疗效果相当,但BS330型降低胆汁酸作用更强。
Objective: To investigate the therapeutic effect of BS330 and AR350 adsorption columns on patients with severe hyperbilirubinemia. Methods: 44 patients with hyperbilirubinemia treated with adsorption columns were collected and divided into BS330 group and AR350 group according to the use of adsorption column. Age,gender,APACHE Ⅱ scores,ICU stay time and prognosis of two groups were collected. TBL,DBL,IDBL,AST,ALT,TBA and PLT were detected before treatment and 30 minutes after adsorption treatment,and the decline rates of the above indicators were compared.Results: There was no significant difference in gender ratio,age,APACHE Ⅱ scores,ICU stay time and prognosis between the two groups( P > 0. 05); Before treatment,there was no significant difference in TBL,DBL,IDBL,AST,ALT,TBA and PLT between two groups( P > 0. 05). After treatment the IDBL of AR350 group was significantly lower than that before treatment( P < 0. 05),while there was no significant difference in other indexes( P > 0. 05),and there was also no significant difference in TBL,DBL,IDBL,ALT,AST and PLT between the two groups( P > 0. 05). TBA decreased rate in BS330 group was significantly higher than that in AR350 group( P < 0. 05).Conclusion: BS330 and AR350 have equivalent efficacy in reducing bilirubin level of patients with severe hyperbilirubinemia,but BS330 has better effect in reducing TBA.

关键词(KeyWords)： 高胆红素血症;肝,人工;胆红素吸附柱;双重血浆分子吸附系统;重症患者;肝功能障碍
hyperbilirubinemia;liver,artificial;bilirubin adsorber;double plasma moleculor absorption system(DPMAS);critical patients;hepatosis

Abstract:

Keywords:

基金项目(Foundation): 贵州省科技计划项目[黔科合LH字(2016)7249];; 吴阶平医学基金会临床科研专项资助基金(320.6750.18001)

作者(Author): 夏云松,付建宇,刘旭,毕红英,陈林林,董奇,唐艳,王迪芬
XIA Yunsong,FU Jianyu,LIU Xu,BI Hongyin,CHEN Linlin,DONG Qi,TANG Yan,WANG Difen

DOI: 10.19367/j.cnki.2096-8388.2020.08.017

参考文献(References)：

• [1]WATCHKO J F,TIRIBELLI C.Bilirubin-induced neurologic damage-mechanisms and management approaches[J].New Engl J Med,2013,369(21):2021-2030．
• [2]李娜，顾欢，朱英，等．肝衰竭治疗的最新进展[J]．医学与哲学，2018,603(39):50-54．
• [3]LODES U,JACOB D.Acute liver failure,acute-on-chronic liver failure,hepatorenal syndrome,hepatopulmonary syndrome and portopulmonary hypertension,ariticial liver support on the ICU[J].Zentralbl Chir,2017,142 (3):275-286．
• [4]SHEN Y,WANG X L,WANG B,et al.Survival benefits with artificial liver support system for acute-on-chronicliver failure:a time series-based meta-analysis[J].Medicine,2016,95:e2506．
• [5]闫国胜，李丽丽，姜少利，等．不同吸附剂在双重血浆分子吸附系统治疗肝衰竭中的临床研究[J]．中华肝脏病杂志，2019,1(27):51-55．
• [6]KRIBBEN A,GERKEN G,HAAG S,et al.Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure[J].Gastroenterology,2012,142(4):782-789．
• [7]BLASCOALGORA S,MASEGOSAATAZ J,GUTIRREZGARCA M L,et al.Acute-on-chronic liver failure:pathogenesis,prognostic factors and management[J].World J Gastroenterol,2015,21(42):12125-12140．
• [8]杨敏，卢明芹．肝细胞性黄疸的诊断与治疗[J]．实用肝脏病杂志，2018,21(2):160-162．
• [9]谢琴芬，程晋坤，郑树森．人工肝支持系统治疗肝功能衰竭的应用进展[J]．现代实用医学，2019,8 (31):1132-1136．
• [10]汪清海，罗开忠，田沂．胆红素吸附治疗慢性重型乙型肝炎的效果及安全性评估[J]．临床肝胆病杂，2016,32(7):1296-1299．
• [11]叶晓玲，程书权，杨景毅，等．不同人工肝方法治疗亚急性重型肝炎的疗效对比研究[J]．重庆医学，2015,44(27):3775-3778．
• [12]熊墨龙，熊云逢，欧阳兵，等．胆红素吸附联合低容量血浆置换治疗重型肝炎的疗效及安全性评估[J]．重庆医学，2018,44(7):923-925．
• [13]叶盛，张晨美．胆红素吸附在肝衰竭挽救性治疗中的应用[J]．中国小儿急救医学，2018,25(5):335-338．
• [14]刘春涛，武瑞，俞海燕，等．双重血浆分子吸附术治疗高胆红素血症的临床研究[J]．浙江临床医学，2019,3(21):341-343．
• [15]李荣华，傅蕾，黄燕，等．双重血浆分子吸附治疗肝衰竭的临床研究[J]．中国现代医学杂志，2019,1(28):78-82．
• [16]秦含玉，贾佳，李国福．双重血浆分子吸附系统治疗急性肝衰竭的临床研究[J]．中华重症医学电子杂志，2018,4(1):31-35．
• [17]周芸．双重血浆分子吸附系统治疗早期肝衰竭的疗效及护理[J]．检验医学与临床，2017,24 (14):3590-3592．
• [18]王盖昊，刘凯辉，张潇艺，等．血浆置换联合血浆灌流治疗急性肝衰竭的临床疗效分析[J]．胃肠病学和肝病学杂志，2017,26(11):1294-1297．
• [19]刘天昭，罗燕．血浆滤过透析治疗慢加急性肝衰竭疗效观察[J]．贵阳中医学院学报，2018,40(3):52-54．
• [20]梁贤栋，张连涛，任志强，等．血浆置换联合胆红素吸附术在重症肝炎中的应用[J]．中国实用医药，2014(29):36-37．
• [21]史昌河，崔伟丽．血浆置换并胆红素吸附治疗肝衰竭的效果[J]．青岛大学医学院学报，2016,52(1):97-98．
• [22]危敏，彭虹，熊庭婷，等．新型人工肝组合技术双重血浆分子吸附联合血浆置换与单纯血浆置换治疗肝衰竭[J]．中国组织工程研究，2019,23 (14):2235-2240．
• [23]钟珊，王娜，赵静，等．血浆置换联合双重血浆吸附治疗提高慢加急性肝衰竭预后[J]．中华肝脏病杂志，2018,26(10):744-749．
• [24]YAO J,LI S,ZHOU L,et al.Therapeutic effect of double lasma molecular adsorption system and sequential halfdose plasma exchange in patients with HBV-relatedacuteon chronic liver failure[J].J Clin Apher,2019:1-7.

文章评论(Comment)：